Libvatrep

DB21488ExperimentalSmall molecule

Libvatrep is a small molecule drug. The usage of the INN stem '-vatrep' in the name indicates that Libvatrep is a transient receptor potential vanilloid (TRPV) antagonist. Libvatrep has a... Libvatrep has a monoisotopic molecular weight of 305.12 Da.

Mechanism: Pharmacologically active on Transient receptor potential cation channel subfamily V member 1
Curator reviewed
Formula / weight: C₁₈H₁₅N₃O₂ · 305.337 g/mol (avg)

Resolves to

Compound

UNII6W8B801TZMCAS871814-52-7ChEMBLCHEMBL5404899

Structure

InChIKeyJFPXRFIBKKSHGY-UHFFFAOYSA-NSMILESCC(C)C1=NC2=CC(O)=CC=C2C(=O)N1C1=CC=C(C=C1)C#N

Targets

Q8NER1TRPV1

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Libvatrep, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account